Editorial: Exploiting multivalency in drug design

Current Pharmaceutical Design

Volumn 15, Issue 6, 2009, Pages 585-586

  Muñoz Torrero, Diego ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTINEOPLASTIC AGENT; DNA; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN P; NITRIC OXIDE DONOR; PROTEASOME; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; LIGAND;

ALZHEIMER DISEASE; BINDING AFFINITY; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; DRUG BINDING SITE; DRUG DESIGN; DRUG EFFICACY; DRUG TARGETING; DRUG TRANSFORMATION; EDITORIAL; HUMAN; PHARMACOPHORE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; BINDING SITE; DRUG DELIVERY SYSTEM;

BINDING SITES; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LIGANDS;

EID: 65549137222     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209787315657     Document Type: Editorial

References (8)

1. Morphy R, Rankovic Z. Designing Multiple Ligands - Medicinal Chemistry Strategies and Challenges. Curr Pharm Des 2009; 15(6): 587-600.
2. Bolognesi ML, Rosini M, Andrisano V, Bartolini M, Minarini A, Tumiatti V, Melchiorre C. MTDL Design Strategy in the Context of Alzheimer's Disease: From Lipocrine to Memoquin and Beyond. Curr Pharm Des 2009; 15(6): 601-613.
3. Martelli A, Breschi MC, Calderone V. Pharmacodynamic Hybrids Coupling Established Cardiovascular Mechanisms of Action with Additional Nitric Oxide Releasing Properties. Curr Pharm Des 2009; 15(6): 614-636.
4. Kim YS, Lee JH, Ryu J, Kim DJ. Multivalent & Multifunctional Ligands to β-Amyloid. Curr Pharm Des 2009; 15(6): 637-658.
5. Chow LMC, Chan TH. Novel Classes of Dimer Antitumour Drug Candidates. Curr Pharm Des 2009; 15(6): 659-674.
6. Shrivastava A, Nunn AD, Tweedle MF. Designer Peptides: Learning from Nature. Curr Pharm Des 2009; 15(6): 675-681.
7. Liu Z, Zhang J, Zhang A. Design of Multivalent Ligand Targeting G-Protein-Coupled Receptors. Curr Pharm Des 2009; 15(6): 682-718.
8. 4 Receptor Oligomers. Curr Pharm Des 2009; 15(6): 719-729.